These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25137052)

  • 1. Doxycycline inducible Krüppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells.
    Chen Z; Wang Y; Liu W; Zhao G; Lee S; Balogh A; Zou Y; Guo Y; Zhang Z; Gu W; Li C; Tigyi G; Yue J
    PLoS One; 2014; 9(8):e105331. PubMed ID: 25137052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
    Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
    Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.
    Wang B; Li X; Zhao G; Yan H; Dong P; Watari H; Sims M; Li W; Pfeffer LM; Guo Y; Yue J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):235. PubMed ID: 30241553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
    Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
    Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition.
    Liu YN; Abou-Kheir W; Yin JJ; Fang L; Hynes P; Casey O; Hu D; Wan Y; Seng V; Sheppard-Tillman H; Martin P; Kelly K
    Mol Cell Biol; 2012 Mar; 32(5):941-53. PubMed ID: 22203039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.
    Lin ZS; Chu HC; Yen YC; Lewis BC; Chen YW
    PLoS One; 2012; 7(8):e43593. PubMed ID: 22937066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 deacetylates KLF4 to activate Claudin-5 transcription in ovarian cancer cells.
    Zhang X; Chen J; Sun L; Xu Y
    J Cell Biochem; 2018 Feb; 119(2):2418-2426. PubMed ID: 28888043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vector expression of Klf4 enhances chondrogenesis and reduces hypertrophy in equine chondrocytes.
    Gurusinghe S; Bandara N; Hilbert B; Trope G; Wang L; Strappe P
    Gene; 2019 Jan; 680():9-19. PubMed ID: 30205175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Lung Cancer Cells and Inhibits Regulating Epithelial-to-Mesenchymal Transition.
    Liu S; Yang H; Chen Y; He B; Chen Q
    Oncol Res; 2016; 24(2):81-7. PubMed ID: 27296948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
    Lee HK; Lee DS; Park JC
    BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.
    Yori JL; Seachrist DD; Johnson E; Lozada KL; Abdul-Karim FW; Chodosh LA; Schiemann WP; Keri RA
    Neoplasia; 2011 Jul; 13(7):601-10. PubMed ID: 21750654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression.
    Yori JL; Johnson E; Zhou G; Jain MK; Keri RA
    J Biol Chem; 2010 May; 285(22):16854-63. PubMed ID: 20356845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.
    Kong F; Sun T; Kong X; Xie D; Li Z; Xie K
    Clin Cancer Res; 2018 May; 24(10):2440-2451. PubMed ID: 29367428
    [No Abstract]   [Full Text] [Related]  

  • 15. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
    Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
    Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells.
    Ji L; Zhao G; Zhang P; Huo W; Dong P; Watari H; Jia L; Pfeffer LM; Yue J; Zheng J
    J Cancer; 2018; 9(24):4578-4585. PubMed ID: 30588241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells.
    Wang B; Shen A; Ouyang X; Zhao G; Du Z; Huo W; Zhang T; Wang Y; Yang C; Dong P; Watari H; Pfeffer LM; Yue J
    Biochem Biophys Res Commun; 2017 Mar; 484(3):486-492. PubMed ID: 28108288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-21 and KLF4 jointly augment epithelial‑mesenchymal transition via the Akt/ERK1/2 pathway.
    Liu CH; Huang Q; Jin ZY; Zhu CL; Liu Z; Wang C
    Int J Oncol; 2017 Apr; 50(4):1109-1115. PubMed ID: 28197636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4.
    Li Q; Song W; Wang W; Yao S; Tian C; Cai X; Wang L
    Oncotarget; 2016 May; 7(20):29749-60. PubMed ID: 27102441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.
    Zhang N; Zhang J; Shuai L; Zha L; He M; Huang Z; Wang Z
    Int J Oncol; 2012 Jun; 40(6):2038-48. PubMed ID: 22407433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.